Switch to:
More From Other Websites
[$$] Amgen's Autumn Gems May 27 2016
Amgen Gets CHMP's Positive Opinion To Extend Indication Of Kyprolis For Relapsed Multiple Myeloma... May 27 2016
7:22 am Amgen confirms receipt of positive CHMP opinion to extend the current indication for... May 27 2016
Amgen Receives Positive CHMP Opinion To Extend Indication Of Kyprolis® (Carfilzomib) For The... May 27 2016
Kyprolis® (Carfilzomib) Demonstrates Economic Value In Relapsed Or Refractory Multiple Myeloma... May 26 2016
Please Gilead, Celgene and Amgen. Don't Buy Medivation. May 26 2016
Amgen, Inc. breached its 50 day moving average in a Bullish Manner : AMGN-US : May 26, 2016 May 26 2016
AMGEN INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 26 2016
Amgen Announces Early Tender Results Of Senior Notes Exchange Offers May 25 2016
Amgen Announces Early Tender Results Of Senior Notes Exchange Offers May 25 2016
Medivation: Three Biotech Giants Enter. Which One Leaves? May 25 2016
Amgen Announces Pricing Terms Of Senior Notes Exchange Offers May 25 2016
Amgen Announces Pricing Terms Of Senior Notes Exchange Offers May 25 2016
Short Sellers Grow More Selective on Major Biotechs May 25 2016
Amgen Senior Leaders Advance Discussion on Cancer at 2016 World Medical Innovation Forum™ May 23 2016
Biotech: The Next Pricing Controversy? May 23 2016
A Rudderless Market May 23 2016
Struggling Novartis heart drug boosted by new medical guidelines May 21 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK